IL-7 producing immunotherapy improves


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
01 Aug 2023
Historique:
medline: 10 7 2023
pubmed: 7 7 2023
entrez: 7 7 2023
Statut: ppublish

Résumé

Following acute stress such as trauma or sepsis, most of critically ill elderly patients become immunosuppressed and susceptible to secondary infections and enhanced mortality. We have developed a virus-based immunotherapy encoding human interleukin-7 (hIL-7) aiming at restoring both innate an adaptative immune homeostasis in these patients. We assessed the impact of this encoded hIL-7 on the

Identifiants

pubmed: 37417353
doi: 10.1080/21645515.2023.2232247
pmc: PMC10332238
doi:

Substances chimiques

Interleukin-7 0
STAT5 Transcription Factor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2232247

Références

PLoS One. 2014 Jan 15;9(1):e83795
pubmed: 24454708
Blood Adv. 2022 Dec 13;6(23):6093-6107
pubmed: 36206199
Exp Gerontol. 2018 May;105:19-26
pubmed: 29427753
Clin Infect Dis. 2016 May 1;62(9):1178-1185
pubmed: 26908786
Front Immunol. 2022 Jul 18;13:917293
pubmed: 35924237
Vaccine. 2013 Sep 6;31(39):4231-4
pubmed: 23523404
Clin Transl Sci. 2020 Nov;13(6):1161-1169
pubmed: 32339447
Immunity. 2010 Jan 29;32(1):91-103
pubmed: 20096608
Front Immunol. 2019 Sep 25;10:2247
pubmed: 31608061
Open Forum Infect Dis. 2014 Aug 26;1(2):ofu074
pubmed: 25734144
Clin Infect Dis. 2012 Jul;55(2):291-300
pubmed: 22550117
JCI Insight. 2018 Jul 12;3(13):
pubmed: 29997288
Nat Rev Immunol. 2013 Dec;13(12):862-74
pubmed: 24232462
J Immunol. 2020 Dec 1;205(11):2968-2978
pubmed: 33106337
Int Orthop. 2019 Jun;43(6):1449-1454
pubmed: 29691612
Front Immunol. 2022 Aug 15;13:939899
pubmed: 36045686
Ann Intensive Care. 2022 Mar 5;12(1):21
pubmed: 35246776
J Immunol. 2022 Jul 1;209(1):99-117
pubmed: 35667841
Hum Vaccin Immunother. 2022 Nov 30;18(6):2133914
pubmed: 36315906
J Immunol. 2010 Apr 1;184(7):3768-79
pubmed: 20200277
J Immunol. 2017 Sep 1;199(5):1606-1615
pubmed: 28724580
J Virol. 2006 Apr;80(7):3532-40
pubmed: 16537621
J Exp Med. 2008 Jul 7;205(7):1701-14
pubmed: 18573906
Semin Immunol. 2012 Jun;24(3):231-40
pubmed: 22421574
Cell Mol Immunol. 2020 Sep;17(9):1001-1003
pubmed: 32728202
Virol J. 2010 Aug 31;7:207
pubmed: 20807412
Crit Rev Immunol. 2018;38(6):433-451
pubmed: 31002599
Clin Cancer Res. 2016 Dec 1;22(23):5898-5908
pubmed: 27407095
Blood. 2006 Apr 1;107(7):2855-62
pubmed: 16357322
PLoS Pathog. 2014 Apr 17;10(4):e1003989
pubmed: 24743339
Surg Today. 2010 Sep;40(9):793-808
pubmed: 20740341
iScience. 2020 Apr 24;23(4):100989
pubmed: 32240954
Sci Rep. 2018 Feb 23;8(1):3529
pubmed: 29476109
Nat Rev Immunol. 2011 May;11(5):330-42
pubmed: 21508983
JAMA Netw Open. 2020 Jul 1;3(7):e2016485
pubmed: 32697322
Methods Mol Biol. 2019;2048:231-243
pubmed: 31396941
Int J Mol Sci. 2017 Aug 10;18(8):
pubmed: 28796199
J Neuroinflammation. 2021 Jun 6;18(1):127
pubmed: 34092245
JCI Insight. 2017 Nov 16;2(22):
pubmed: 29202461
J Immunol. 2022 Feb 1;208(3):562-570
pubmed: 35031578
Mil Med Res. 2019 Apr 24;6(1):11
pubmed: 31014397
Eur J Immunol. 2016 May;46(5):1168-79
pubmed: 26910859
Blood. 2003 Aug 15;102(4):1534-40
pubmed: 12714515
J Immunol. 2005 Dec 15;175(12):8415-23
pubmed: 16339584
Cytokine Growth Factor Rev. 2005 Aug-Oct;16(4-5):513-33
pubmed: 15996891
Shock. 2020 Aug;54(2):144-153
pubmed: 31764618
Cells. 2019 Nov 27;8(12):
pubmed: 31783629
Front Immunol. 2021 Dec 10;12:680442
pubmed: 34956167
Cancer Immunol Immunother. 2016 Apr;65(4):441-52
pubmed: 26850637
Toxicol Appl Pharmacol. 2021 Feb 15;413:115406
pubmed: 33434572
J Virol. 2007 Nov;81(22):12102-10
pubmed: 17855554
Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16601-6
pubmed: 20823247
Front Immunol. 2021 Dec 02;12:747324
pubmed: 34925323
AIDS. 2016 Jan;30(2):221-30
pubmed: 26684819
Indian J Med Res. 2011 Dec;134(6):972-81
pubmed: 22310831
J Immunol. 2012 Dec 15;189(12):5541-8
pubmed: 23136199
PLoS One. 2016 Nov 17;11(11):e0166280
pubmed: 27855183
Sci Rep. 2022 Jan 7;12(1):135
pubmed: 34997007
Sci Rep. 2019 Sep 9;9(1):12887
pubmed: 31501486
Lab Med. 2017 Feb;48(1):57-64
pubmed: 27760802
Front Immunol. 2020 Sep 18;11:571759
pubmed: 33072114
JCI Insight. 2018 Mar 8;3(5):
pubmed: 29515037
Langenbecks Arch Surg. 2005 Aug;390(4):333-41
pubmed: 15995884
Exp Gerontol. 2001 Nov;36(10):1749-59
pubmed: 11672994
Semin Immunopathol. 2020 Oct;42(5):521-536
pubmed: 32930852
Aging Clin Exp Res. 2021 Mar;33(3):729-732
pubmed: 31522388
Hum Immunol. 2022 Dec;83(12):808-817
pubmed: 36229379
J Clin Med. 2020 Jan 10;9(1):
pubmed: 31936748
Open Forum Infect Dis. 2021 May 23;8(6):ofab256
pubmed: 34189174
Adv Virus Res. 2017;97:187-243
pubmed: 28057259
J Leukoc Biol. 2017 Feb;101(2):543-554
pubmed: 27630218
Infect Drug Resist. 2020 Jun 30;13:2053-2061
pubmed: 32636658
J Immunol. 2005 Jun 1;174(11):6571-6
pubmed: 15905493
Clin Transl Immunology. 2016 Apr 29;5(4):e77
pubmed: 27195120
J Immunol Res. 2017;2017:4807853
pubmed: 28484723
JCI Insight. 2020 Sep 3;5(17):
pubmed: 32687484
Front Immunol. 2018 Dec 21;9:2736
pubmed: 30619240
Int J Mol Sci. 2022 Mar 21;23(6):
pubmed: 35328795
Int J Mol Sci. 2022 Sep 08;23(18):
pubmed: 36142322
Blood. 2003 Apr 1;101(7):2711-20
pubmed: 12433688
J Immunol. 2019 Apr 1;202(7):1962-1969
pubmed: 30737273
Front Immunol. 2021 Sep 17;12:737406
pubmed: 34603318
J Thromb Haemost. 2005 Sep;3(9):2006-14
pubmed: 16102107
Ageing Res Rev. 2021 Jan;65:101231
pubmed: 33248315
Int J Mol Sci. 2015 May 06;16(5):10267-80
pubmed: 25955647
Cells. 2022 May 20;11(10):
pubmed: 35626739
Ageing Res Rev. 2021 Nov;71:101422
pubmed: 34391943
Crit Care Med. 2022 Jun 1;50(6):e618
pubmed: 35617575

Auteurs

Chrystel Marton (C)

Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Inserm, CIMI-Paris, Paris, France.
ImmmunResQ Department, Transgene, Lyon, France.

Alix Minaud (A)

Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Inserm, CIMI-Paris, Paris, France.

Charles-Antoine Coupet (CA)

ImmmunResQ Department, Transgene, Lyon, France.

Manon Chauvin (M)

Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Inserm, CIMI-Paris, Paris, France.

Jamila Dhiab (J)

Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Inserm, CIMI-Paris, Paris, France.

Hélène Vallet (H)

Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Inserm, CIMI-Paris, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Unité de Gériatrie Aigue, Paris, France.

Jacques Boddaert (J)

Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Inserm, CIMI-Paris, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpétrière, Unité périopératoire gériatrique, Paris, France.

Nadine Kehrer (N)

ImmmunResQ Department, Transgene, Lyon, France.

Bérangère Bastien (B)

Biometry and Statistic Department, Transgene, Strasbourg, France.

Geneviève Inchauspe (G)

ImmmunResQ Department, Transgene, Lyon, France.

Luc Barraud (L)

ImmmunResQ Department, Transgene, Lyon, France.

Delphine Sauce (D)

Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Inserm, CIMI-Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH